<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph-family" /><meta name="keywords" content="Allergy: anaphylaxis; Shock: anaphylactic; Anaphylaxis; Anaphylactic shock; Arachis oil: presence of; Adrenaline: anaphylaxis; Oxygen: anaphylaxis; Antihistamines: allergic emergencies; Corticosteroids: allergic emergencies" /><meta name="IX" content="Allergy: anaphylaxis; Shock: anaphylactic; Anaphylaxis; Anaphylactic shock; Arachis oil: presence of; Adrenaline: anaphylaxis; Oxygen: anaphylaxis; Antihistamines: allergic emergencies; Corticosteroids: allergic emergencies" /><title>Anaphylaxis: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="201198.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="201198.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=201198.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="1008.htm">3 Respiratory system</a> &gt; <a href="3017.htm">3.4 Antihistamines, hyposensitisation, and allergic emergencies</a> &gt; <a href="3121.htm">3.4.3 Allergic emergencies</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3121.htm" title="Previous: 3.4.3 Allergic emergencies">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="201200.htm" title="Next: Intramuscular adrenaline (epinephrine)">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_201198">Anaphylaxis</h1><?highlighter on?><div id="pC" class="jN"><div><p>Anaphylaxis is a severe, life-threatening, generalised or systemic
hypersensitivity reaction. It is characterised by the rapid onset
of respiratory and/or circulatory problems and is usually associated
with skin and mucosal changes; prompt treatment is required. Patients
with pre-existing asthma, especially poorly controlled asthma, are
at particular risk of life-threatening reactions. Insect stings are
a recognised risk (in particular wasp and bee stings). Latex and certain
foods, including eggs, fish, cow’s milk protein, peanuts, sesame,
shellfish, soy, and tree nuts may also precipitate anaphylaxis. Medicinal
products particularly associated with anaphylaxis include blood products,
vaccines, hyposensitising (allergen) preparations, <span>antibacterials</span>, <span>aspirin</span> and other NSAIDs, and neuromuscular
blocking drugs. In the case of drugs, anaphylaxis is more likely after
parenteral administration; resuscitation facilities must always be
available for injections associated with special risk. Anaphylactic
reactions may also be associated with <i>additives and excipients</i> in foods and medicines. Refined arachis (peanut) oil, which may be present
in some medicinal products, is unlikely to cause an allergic reaction—nevertheless
it is wise to check the full formula of preparations which may contain
allergens.</p><p><i>First-line treatment of anaphylaxis</i> includes
securing the airway, restoration of blood pressure (laying the patient
flat and raising the legs, or in the recovery position if unconscious
or nauseated and at risk of vomiting) and administration of <b>adrenaline</b> (epinephrine) injection. Adrenaline is given <b>intramuscularly </b>in a dose of 500 micrograms (0.5 mL adrenaline injection 1 in 1000);
a dose of 300 micrograms (0.3 mL adrenaline injection 1 in 1000) may
be appropriate for <i>immediate self-administration</i>.
The dose is repeated if necessary at 5-minute intervals according
to blood pressure, pulse, and respiratory function (<b>important:</b> possible need for <i>intravenous route</i> using <i>dilute solution</i>, see <a title="BNF:monograph-subgroup: Intramuscular adrenaline (epinephrine)" href="201200.htm#_201200">below</a>).  Patients receiving beta-blockers
require special consideration (see under <a title="monograph: ADRENALINE/EPINEPHRINE" href="100076.htm#_100076">Adrenaline</a>). High-flow <b>oxygen</b> administration (<a title="BNF:section: Oxygen" href="3058.htm#_3058">section 3.6</a>) and intravenous fluids (<a title="sub-section: Parenteral preparations for fluid and electrolyte imbalance" href="4970.htm#_4970">section 9.2.2</a>) are also
of primary importance. An antihistamine (e.g. <b>chlorphenamine</b>, given by slow intravenous injection or intramuscular injection
in a dose of 10 mg, see under <a title="monograph: CHLORPHENAMINE MALEATE/CHLORPHENIRAMINE MALEATE" href="3036.htm#_3036">Chlorphenamine</a>) is a useful adjunctive treatment, given after adrenaline. An intravenous corticosteroid
e.g. <b><span>hydrocortisone</span></b> (preferably
as sodium succinate) in a dose of 200 mg (<a title=" Glucocorticoid therapy" href="4255.htm#_4255">section 6.3.2</a>) is of secondary value in the initial management
of anaphylaxis because the onset of action is delayed for several
hours, but should be given to prevent further deterioration in severely
affected patients.</p><p><i>Continuing respiratory deterioration</i> requires
further treatment with <b>bronchodilators</b> including
inhaled or intravenous salbutamol (see under <a title="monograph: SALBUTAMOL" href="2879.htm#_2879">Salbutamol</a>), inhaled ipratropium (see under <a title="monograph: IPRATROPIUM BROMIDE" href="2925.htm#_2925">Ipratropium</a>), intravenous
aminophylline (see under <a title="monograph: AMINOPHYLLINE" href="2939.htm#_2939">Aminophylline</a>), or intravenous magnesium
sulphate [unlicensed indication] (see <a title="sub-topic: Acute severe asthma" href="100061.htm#_100061">Acute Severe Asthma</a>); in
addition to oxygen, assisted respiration and possibly emergency tracheotomy
may be necessary. </p><p>When a patient is so ill that there is doubt about the adequacy
of the circulation, the initial injection of adrenaline may need to
be given as a <i>dilute solution by the intravenous route</i>; for details of cautions, dose, and strength, see under <a title="BNF:monograph-subgroup: Intravenous adrenaline (epinephrine)" href="201201.htm#_201201">Intravenous Adrenaline (Epinephrine)</a>.</p><p>Cardiopulmonary arrest may follow an anaphylactic reaction;
resuscitation should be started immediately (see <a title="sub-section: Cardiopulmonary resuscitation" href="27050.htm#_27050">Cardiopulmonary Resuscitation</a>).</p><p>For advice on the management of medical emergencies in dental
practice, see <a title="sub-topic: Anaphylaxis" href="128362.htm#_128362">Prescribing in Dental Practice</a>.</p><p>On discharge, patients should be considered for further treatment
with an oral antihistamine (<a title="BNF:sub-section: Antihistamines" href="3018.htm#_3018">section 3.4.1</a>) and an oral corticosteroid (<a title="BNF:sub-section: Glucocorticoid therapy" href="4255.htm#_4255">section 6.3.2</a>) for up to 3 days to reduce the
risk of further reaction. Patients should be instructed to return
to hospital if symptoms recur and to contact their general practitioner
for follow-up.</p><p>Patients who are suspected of having had an anaphylactic reaction
should be referred to a specialist for specific allergy diagnosis.
Avoidance of the allergen is the principal treatment; if appropriate,
an adrenaline auto-injector should be given or a replacement supplied
(see <a title="BNF:monograph-subgroup: Self-administration of adrenaline (epinephrine)" href="201202.htm#_201202">Self-administration of Adrenaline</a>).</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="201200.htm" title="Intramuscular adrenaline (epinephrine)">Intramuscular adrenaline (epinephrine)</a></li><li><a href="201201.htm" title="Intravenous adrenaline (epinephrine)">Intravenous adrenaline (epinephrine)</a></li><li><a href="201202.htm" title="Self-administration of adrenaline (epinephrine)">Self-administration of adrenaline (epinephrine)</a></li><li id="_100076"><a href="100076.htm" title="ADRENALINE/EPINEPHRINE">ADRENALINE/EPINEPHRINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3121.htm">Previous: 3.4.3 Allergic emergencies</a> | <a class="top" href="201198.htm#">Top</a> | <a accesskey="]" href="201200.htm">Next: Intramuscular adrenaline (epinephrine)</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>